Timber Pharmaceuticals, Inc.
TMBR
TMBR was delisted on the 28th of November, 2023.
15 hedge funds and large institutions have $2.23M invested in Timber Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 5 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
168% more capital invested
Capital invested by funds: $835K → $2.23M (+$1.4M)
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
15% more funds holding
Funds holding: 13 → 15 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.28M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$189K |
| 3 |
Renaissance Technologies
New York
|
+$167K |
| 4 |
State Street
Boston,
Massachusetts
|
+$152K |
| 5 |
BlackRock
New York
|
+$132K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$207K |
| 2 |
Jane Street
New York
|
-$92K |
| 3 |
Bank of New York Mellon
New York
|
-$49K |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$45K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$11.8K |
TMBR Hedge Fund Activity: Q2 2021 in Review
15 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q2 2021, worth a combined $2.23M — up 168% from $835K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new TMBR positions and 5 closed out — a net gain of 2 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.28M. The largest seller was Cetera Advisor Networks, exiting entirely with an estimated $207K sold.
- 15 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q2 2021, up from 13 in Q1 2021.
- Funds reported $2.23M of Timber Pharmaceuticals, Inc. stock for Q2 2021, up 168% quarter-over-quarter.
- 7 funds opened new Timber Pharmaceuticals, Inc. positions in Q2 2021 and 5 closed out, a net change of +2 holders.
- The largest Timber Pharmaceuticals, Inc. buyer in Q2 2021 was Vanguard Group, an estimated $1.28M added.
- The largest Timber Pharmaceuticals, Inc. seller in Q2 2021 was Cetera Advisor Networks, an estimated $207K sold.
Based on aggregated 13F filings for Q2 2021.